Scarring cells revert to inactive state as liver heals
An international team of scientists, led by researchers at the University of California, San Diego School of Medicine, report that significant numbers of myofibroblasts – cells that produce the fibrous ...
Medical research
May 07, 2012 |
5 / 5 (5) |
1
|
Comorbidities increase risk of mortality in COPD patients
Comorbidities are common among patients with chronic obstructive pulmonary disease (COPD), and a number of these comorbidities are independently associated with an increased mortality risk, according to a new study.
Diseases, Conditions, Syndromes
May 04, 2012 |
not rated yet |
0
Fibrosis and fatty liver disease increase risk of early atherosclerosis
Italian researchers report that severe fibrosis increases the early atherosclerosis risk in patients with genotype 1 chronic hepatitis C virus (HCV) infection. A second study found that fatty liver disease also increases ...
Diseases, Conditions, Syndromes
Apr 24, 2012 |
not rated yet |
0
Broader screening for hepatitis C would be cost effective, study suggests
Broader screening to identify people infected with hepatitis C virus (HCV) would likely be cost effective, according to a new report published in Clinical Infectious Diseases and available online. Significantly reducing HCV-related mortality and morbidity, however, will require a coordinated ...
Diseases, Conditions, Syndromes
Mar 14, 2012 |
not rated yet |
0
Coffee consumption reduces fibrosis risk in those with fatty liver disease
Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, newly published research confirms that coffee caffeine consumption reduces ...
Diseases, Conditions, Syndromes
Feb 02, 2012 |
5 / 5 (1) |
0
New fibrosis classification improves accuracy of diagnosis in hepatitis C
A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January ...
Diseases, Conditions, Syndromes
Jan 10, 2012 |
not rated yet |
0
Gene variant increases fatty liver risk and fibrosis progression
New research confirms that a variant on the patatin-like phospholipase-3 (PNPLA3) gene increases risk of steatosis and fibrosis progression in patients with chronic hepatitis C virus (HCV). The PNPLA3 single nucleotide polymorphism ...
Genetics
Jun 28, 2011 |
not rated yet |
0
Noninvasive liver tests may predict hepatitis C patient survival
Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, the official journal of the ...
Diseases, Conditions, Syndromes
Jun 14, 2011 |
not rated yet |
0
Noninvasive diagnostics may offer alternative to liver biopsy for assessing liver fibrosis
Patients who are evaluated for liver diseases such as hepatitis C (HCV) are typically recommended for liver biopsy to determine the extent of disease progression. For patients who question whether less invasive testing is ...
Diseases, Conditions, Syndromes
Jun 02, 2011 |
not rated yet |
0
- Pages: 1 2
